I for one apologize Steve; this is most definitely not the "big news" I wanted to hear; it's actually the opposite. Let me summarize my sentiment: F'k me.
Everyone wasn't expecting a buyout. Some of us are just investing in an undervalued bio expecting the hold to be lifted and axal to be monetized followed by other partnerships which could lead to substantial gains. I think an axal deal will come shortly after the hold is resolved hopefully followed by partnerships for other constructs. $6 to $8 by end of year if this new CEO can get it done.
News 
Market Data 
Discover 
